2019 – ESSA Pharma

Date	Title
August 14, 2019	ESSA Pharma Provides Corporate Update and Reports Financial Results for the Fiscal Third Quarter Ended June 20, 2019
July 31, 2019	ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective
July 30, 2019	ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
July 8, 2019	ESSA Provides Update on Court Hearing
June 26, 2019	ESSA Provides Update to the Acquisition of Realm Therapeutics
June 25, 2019	ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders
June 21, 2019	ESSA Pharma to Hold Annual Shareholders’ Meeting and Announces Three Realm-Nominated Directors
May 16, 2019	Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics – Acquisition Expected to be Completed by Mid-Year 2019
May 10, 2019	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019.
May 4, 2019	Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting